Included studies will be critically appraised by two independent reviewers using standardized critical appraisal instruments from JBI. Data will be extracted from studies included in the review using a standardized extraction tool. Studies will, where possible, be pooled in statistical meta-analysis using JBI SUMARI. The title of this protocol has been registered with the JBI Systematic Review Register. This manuscript has been registered with PROSPERO (CRD42020177756).The title of this protocol has been registered with the JBI Systematic Review Register. This manuscript has been registered with PROSPERO (CRD42020177756). The objective of this review is to evaluate the association between organic food consumption and the incidence of cancer among adults. Organic foods differ from traditional food in the methods in which they are produced. There is literature to suggest that they are associated with better health outcomes, including a lower incidence of some cancers. The association between organic food consumption and the incidence of cancer has not yet been synthesized. Studies that compared organic food consumption to conventional food consumption, measured the incidence of cancer among adults, and captured disease incidence, such as prospective and retrospective cohort methodologies, will be included. A comprehensive search strategy will be implemented to retrieve relevant studies from PubMed, CINAHL, LILACS, EMBASE, PsycINFO, Science.gov, Web of Science/Web of Knowledge, and Academic Search Premiere, as well as gray literature sources such as Google Scholar, DARE and Dissertation Abstracts International. Selleck MYCMI-6 The search parameters will include studies for which the full text in English is available, and studies dated 2009 or later, as this was the date of a previous systematic review on the association between organic food consumption and health outcomes that did not find any studies with cancer-related outcomes. Study screening, critical appraisal, and data extraction will be performed independently by pairs of reviewers among the authorship team. Data synthesis will include narrative review and meta-analysis if appropriate. PROSPERO (CRD42019126224).PROSPERO (CRD42019126224). The objective of this review is to identify the most frequently used protocols for analyzing the myoelectric activity of the pelvic floor muscles during surface electromyography in women aged 18 years or older. Surface electromyography is normally used in assessment and treatment for research purposes when it is intended to quantitatively measure the electrophysiological behavior of the neuromuscular system. However, although there are internationally standardized, non-invasive assessment protocols for most muscle groups, there is no consensus for pelvic floor muscles, which makes it difficult to standardize in scientific research and clinical applicability. Studies that explore registration protocols and filtering parameters of surface electromyographic signals in women aged over 18 years old with or without pelvic floor dysfunction will be considered. Studies encompassing either electromyographic biofeedback as a treatment resource only or electroneuromyography (needle electrode) will be excluded. Pn by title, abstract, and full text. If there is any disagreement, a third reviewer will be consulted. Data will be extracted and organized in standardized spreadsheets. The results will be assigned to categories in order to facilitate the organization of a protocol with the most commonly used parameters for non-invasive assessment of myoelectric activity of pelvic floor muscles. Persons living with dementia require assistance in making day-to-day and health care decisions. Health care professionals select treatments based on the care partner (CP) report of the person's function; however, the accuracy of CPs' appraisal has received limited exploration. Retrospective analyses of observational, programmatic data were performed across 161 dyads (CPs and persons with dementia) participating in an evidence-based, community-level dementia intervention program. We examined the differences in the appraisal of activities of daily living performance by CPs versus occupational therapists specialized in dementia treatment and investigated factors related to this discrepancy. The discrepancy in the assessment of function is common between CPs and clinicians. CPs tend to overestimate the abilities of persons with dementia. Appraisal discrepancy was most strongly associated with (1) sex of the person with dementia, (2) timing of assessment performance, (3) number of behavioral symptoms of the person with dementia, and (4) cognitive abilities of the person with dementia. Many factors influence the ability of CPs to appraise the function of persons with dementia. The inaccurate appraisal could result in insufficient daily assistance for, or even unnecessary health care utilization, of the person with dementia. Timeliness of intervention is crucial as their health status may change quickly.Many factors influence the ability of CPs to appraise the function of persons with dementia. The inaccurate appraisal could result in insufficient daily assistance for, or even unnecessary health care utilization, of the person with dementia. Timeliness of intervention is crucial as their health status may change quickly.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the least deadly but most infectious coronavirus strain transmitted from wild animals. It may affect many organ systems. Aim of the current guideline is to delineate the effects of SARS-CoV-2 on the liver. Asymptomatic aminotransferase elevations are common in coronavirus disease 2019 (COVID-19) disease. Its pathogenesis may be multifactorial. It may involve primary liver injury and indirect effects such as "bystander hepatitis," myositis, toxic liver injury, hypoxia, and preexisting liver disease. Higher aminotransferase elevations, lower albumin, and platelets have been reported in severe compared with mild COVID-19. Despite the dominance of respiratory disease, acute on chronic liver disease/acute hepatic decompensation have been reported in patients with COVID-19 and preexisting liver disease, in particular cirrhosis. Metabolic dysfunction-associated fatty liver disease (MAFLD) has a higher risk of respiratory disease progression than those without MAFLD.